Etanercept-Induced Encephalopathy in a 7-Year-Old Child

详细信息    查看全文

• 作者：Bar?? Ekici ; MD^a ; ^{ekicibaris@yahoo.com} ; Kubilay Ayd?n ; MD^b ; Serdar Cantez ; MD^c ; Yakup Erg&uuml ; l ; MD^c ; Burak Tatl? ; MD^a
• 刊名：Pediatric Neurology
• 出版年：2011
• 出版时间：October, 2011
• 年：2011
• 卷：45
• 期：4
• 页码：271-273
• 全文大小：1K

文摘

Adverse events were reported in various patients treated with etanercept, including infections (sepsis and tuberculosis), malignancies (e.g., lymphoma), demyelinating disorders, and autoimmune diseases. Only two adult patients with etanercept-related encephalopathy were previously reported. We describe a 7-year-old patient who developed encephalopathy immediately after his third dose of etanercept. To the best of our knowledge, ours is the first report of a pediatric patient with a diagnosis of systemic arthritis and who developed etanercept-related encephalopathy.